359 related articles for article (PubMed ID: 23653385)
1. An updated review on drug-induced cholestasis: mechanisms and investigation of physicochemical properties and pharmacokinetic parameters.
Yang K; Köck K; Sedykh A; Tropsha A; Brouwer KL
J Pharm Sci; 2013 Sep; 102(9):3037-57. PubMed ID: 23653385
[TBL] [Abstract][Full Text] [Related]
2. Development of a mechanistic biokinetic model for hepatic bile acid handling to predict possible cholestatic effects of drugs.
Notenboom S; Weigand KM; Proost JH; van Lipzig MMH; van de Steeg E; van den Broek PHH; Greupink R; Russel FGM; Groothuis GMM
Eur J Pharm Sci; 2018 Mar; 115():175-184. PubMed ID: 29309877
[TBL] [Abstract][Full Text] [Related]
3. Bile Acids in Cholestasis and its Treatment.
Arab JP; Cabrera D; Arrese M
Ann Hepatol; 2017 Nov; 16(Suppl. 1: s3-105.):s53-s57. PubMed ID: 29080340
[TBL] [Abstract][Full Text] [Related]
4. Hepatobiliary transporters in drug-induced cholestasis: a perspective on the current identifying tools.
de Lima Toccafondo Vieira M; Tagliati CA
Expert Opin Drug Metab Toxicol; 2014 Apr; 10(4):581-97. PubMed ID: 24588537
[TBL] [Abstract][Full Text] [Related]
5. Bile acid transporters: structure, function, regulation and pathophysiological implications.
Alrefai WA; Gill RK
Pharm Res; 2007 Oct; 24(10):1803-23. PubMed ID: 17404808
[TBL] [Abstract][Full Text] [Related]
6. Bile salts and cholestasis.
Maillette de Buy Wenniger L; Beuers U
Dig Liver Dis; 2010 Jun; 42(6):409-18. PubMed ID: 20434968
[TBL] [Abstract][Full Text] [Related]
7. Alpha-naphthylisothiocyanate impairs bile acid homeostasis through AMPK-FXR pathways in rat primary hepatocytes.
Li X; Liu R; Yu L; Yuan Z; Sun R; Yang H; Zhang L; Jiang Z
Toxicology; 2016 Aug; 370():106-115. PubMed ID: 27702592
[TBL] [Abstract][Full Text] [Related]
8. Hepatobiliary transporter expression in percutaneous liver biopsies of patients with cholestatic liver diseases.
Zollner G; Fickert P; Zenz R; Fuchsbichler A; Stumptner C; Kenner L; Ferenci P; Stauber RE; Krejs GJ; Denk H; Zatloukal K; Trauner M
Hepatology; 2001 Mar; 33(3):633-46. PubMed ID: 11230744
[TBL] [Abstract][Full Text] [Related]
9. Predictive Value of Cellular Accumulation of Hydrophobic Bile Acids As a Marker of Cholestatic Drug Potential.
Burban A; Sharanek A; Humbert L; Eguether T; Guguen-Guillouzo C; Rainteau D; Guillouzo A
Toxicol Sci; 2019 Apr; 168(2):474-485. PubMed ID: 30629237
[TBL] [Abstract][Full Text] [Related]
10. Expression of the bile salt export pump is maintained after chronic cholestasis in the rat.
Lee JM; Trauner M; Soroka CJ; Stieger B; Meier PJ; Boyer JL
Gastroenterology; 2000 Jan; 118(1):163-72. PubMed ID: 10611165
[TBL] [Abstract][Full Text] [Related]
11. Early Alterations of Bile Canaliculi Dynamics and the Rho Kinase/Myosin Light Chain Kinase Pathway Are Characteristics of Drug-Induced Intrahepatic Cholestasis.
Burbank MG; Burban A; Sharanek A; Weaver RJ; Guguen-Guillouzo C; Guillouzo A
Drug Metab Dispos; 2016 Nov; 44(11):1780-1793. PubMed ID: 27538918
[TBL] [Abstract][Full Text] [Related]
12. Hepatobiliary transporters and drug-induced cholestasis.
Pauli-Magnus C; Meier PJ
Hepatology; 2006 Oct; 44(4):778-87. PubMed ID: 17006912
[TBL] [Abstract][Full Text] [Related]
13. Drug-induced perturbations of the bile acid pool, cholestasis, and hepatotoxicity: mechanistic considerations beyond the direct inhibition of the bile salt export pump.
Rodrigues AD; Lai Y; Cvijic ME; Elkin LL; Zvyaga T; Soars MG
Drug Metab Dispos; 2014 Apr; 42(4):566-74. PubMed ID: 24115749
[TBL] [Abstract][Full Text] [Related]
14. Protective effects of inhaled carbon monoxide in endotoxin-induced cholestasis is dependent on its kinetics.
Vanova K; Suk J; Petr T; Cerny D; Slanar O; Vreman HJ; Wong RJ; Zima T; Vitek L; Muchova L
Biochimie; 2014 Feb; 97():173-80. PubMed ID: 24148277
[TBL] [Abstract][Full Text] [Related]
15. Model Systems for Studying the Role of Canalicular Efflux Transporters in Drug-Induced Cholestatic Liver Disease.
Stieger B; Mahdi ZM
J Pharm Sci; 2017 Sep; 106(9):2295-2301. PubMed ID: 28385542
[TBL] [Abstract][Full Text] [Related]
16. Hepatocellular transport in acquired cholestasis: new insights into functional, regulatory and therapeutic aspects.
Roma MG; Crocenzi FA; Sánchez Pozzi EA
Clin Sci (Lond); 2008 May; 114(9):567-88. PubMed ID: 18377365
[TBL] [Abstract][Full Text] [Related]
17. Serotonin protects mouse liver from cholestatic injury by decreasing bile salt pool after bile duct ligation.
Jang JH; Rickenbacher A; Humar B; Weber A; Raptis DA; Lehmann K; Stieger B; Moritz W; Soll C; Georgiev P; Fischer D; Laczko E; Graf R; Clavien PA
Hepatology; 2012 Jul; 56(1):209-18. PubMed ID: 22290718
[TBL] [Abstract][Full Text] [Related]
18. Geniposide attenuates ANIT-induced cholestasis through regulation of transporters and enzymes involved in bile acids homeostasis in rats.
Wang L; Wu G; Wu F; Jiang N; Lin Y
J Ethnopharmacol; 2017 Jan; 196():178-185. PubMed ID: 27988401
[TBL] [Abstract][Full Text] [Related]
19. Adenovirus-mediated human aquaporin-1 expression in hepatocytes improves lipopolysaccharide-induced cholestasis.
Marrone J; Danielli M; Gaspari CI; Marinelli RA
IUBMB Life; 2017 Dec; 69(12):978-984. PubMed ID: 29087027
[TBL] [Abstract][Full Text] [Related]
20. Metformin Disrupts Bile Acid Efflux by Repressing Bile Salt Export Pump Expression.
Garzel B; Hu T; Li L; Lu Y; Heyward S; Polli J; Zhang L; Huang SM; Raufman JP; Wang H
Pharm Res; 2020 Jan; 37(2):26. PubMed ID: 31907698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]